Oral dextrose gel for the prevention of hypoglycaemia in newborn infants

To assess whether oral dextrose gel in infants at risk of neonatal hypoglycaemia is more effective than placebo or no treatment or other active therapies (such as antenatal expression of colostrum, early initiation of breastfeeding, supplementation or substitution of breastfeeding with formula milk) in:

  • preventing hypoglycaemia in newborn infants;
  • reducing developmental impairments at childhood follow-up.

This is a protocol.